Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
13 pending office actions • 7 art units • 10 examiners • 0 of 13 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Genomatica Inc. has 13 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 11 examiners and 8 art units, showing distribution across several examination settings with some repeated examiner and art-unit assignments.
SAIDHA, TEKCHAND is the listed busiest examiner, with 2 pending matters. That assignment creates a modest concentration point, while the remaining matters are distributed among other examiners.
The art-unit structure provides a useful basis for comparing treatment of related biotechnology claims. Matters sharing an art unit may offer context for response planning, but the examiner spread means that prosecution positions should not be assumed to receive uniform treatment.
A portfolio-level review can track recurring claim language, written-description support, and prior-art distinctions. Counsel can then adapt those positions to the individual examiner records while using the shared art-unit context to identify consistent technical themes.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 3 (23%) |
| §102 only | 1 (8%) |
| §112 only | 1 (8%) |
| Double-patenting only | 1 (8%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAIDHA, TEKCHAND | 2 | 82.9% | +14.0% |
| RAMIREZ, DELIA M | 2 | 65.1% | +56.3% |
| HOBSON, STEPHEN | 2 | 65.0% | +20.1% |
| HUTSON, RICHARD G | 1 | 65.1% | +52.9% |
| DUBOIS, PHILIP A | 1 | 25.6% | +26.3% |
| SINGH, SATYENDRA K | 1 | 61.5% | +67.9% |
| MURESAN, ANA Z | 1 | 75.0% | +31.2% |
| JONES-FOSTER, ERICA NICOLE | 1 | 49.4% | +44.0% |
| ROBINSON, HOPE A | 1 | 67.7% | +43.0% |
| QIAN, CELINE X | 1 | 47.5% | +17.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18937302 | THIOESTERASE VARIANTS HAVING IMPROVED ACTIVITY FOR THE PRODUCTION OF MEDIUM-CHAIN FATTY ACID DERIVATIVES | SAIDHA, TEKCHAND | — |
| 18701533 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | SAIDHA, TEKCHAND | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18853349 | NEUTRAL TASTE 1,3-BUTYLENE GLYCOL PRODUCTS AND COMPOSITIONS THEREOF | DUBOIS, PHILIP A | — |
| 18242912 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | RAMIREZ, DELIA M | — |
| 18260225 | Methods and Compositions for Making Amide Compounds | JONES-FOSTER, ERICA NICOLE | — |
| 17996921 | ENGINEERED ENZYMES AND METHODS OF MAKING AND USING | RAMIREZ, DELIA M | — |
| 17780421 | ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-CoA-DERIVED PRODUCTS | QIAN, CELINE X | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17843589 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | ROBINSON, HOPE A | 31d overdue |
| 15651929 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | HOBSON, STEPHEN | 10d overdue |
| 18469170 | PROCESS AND SYSTEMS FOR OBTAINING 1,3-BUTANEDIOL FROM FERMENTATION BROTHS | MURESAN, ANA Z | 13d |
| 19008032 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | HUTSON, RICHARD G | — |
| 18937302 | THIOESTERASE VARIANTS HAVING IMPROVED ACTIVITY FOR THE PRODUCTION OF MEDIUM-CHAIN FATTY ACID DERIVATIVES | SAIDHA, TEKCHAND | — |
| 18853349 | NEUTRAL TASTE 1,3-BUTYLENE GLYCOL PRODUCTS AND COMPOSITIONS THEREOF | DUBOIS, PHILIP A | — |
| 18701533 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | SAIDHA, TEKCHAND | — |
| 18580585 | FORMATE DEHYDROGENASE VARIANTS AND METHODS OF USE | SINGH, SATYENDRA K | — |
| Art Unit | Apps |
|---|---|
| 1652 | 6 |
| 1776 | 2 |
| 1791 | 1 |
| 1657 | 1 |
| 1692 | 1 |
| 1656 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19008032 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | HUTSON, RICHARD G | 1652 | §102§112DP | Non-Final OA | — | Pending | Jan 02, 2025 |
| 18937302 | THIOESTERASE VARIANTS HAVING IMPROVED ACTIVITY FOR THE PRODUCTION OF MEDIUM-CHAIN FATTY ACID DERIVATIVES | SAIDHA, TEKCHAND | 1652 | DP | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18853349 | NEUTRAL TASTE 1,3-BUTYLENE GLYCOL PRODUCTS AND COMPOSITIONS THEREOF | DUBOIS, PHILIP A | 1791 | §102§103§112 | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18701533 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | SAIDHA, TEKCHAND | 1652 | §102§112DP | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18580585 | FORMATE DEHYDROGENASE VARIANTS AND METHODS OF USE | SINGH, SATYENDRA K | 1657 | §102 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18469170 | PROCESS AND SYSTEMS FOR OBTAINING 1,3-BUTANEDIOL FROM FERMENTATION BROTHS | MURESAN, ANA Z | 1692 | §103 | Non-Final OA | 13d | Pending | Sep 18, 2023 |
| 18242912 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | RAMIREZ, DELIA M | 1652 | §102§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18260225 | Methods and Compositions for Making Amide Compounds | JONES-FOSTER, ERICA NICOLE | 1656 | §103§112 | Final Rejection | — | Pending | Jun 30, 2023 |
| 17996921 | ENGINEERED ENZYMES AND METHODS OF MAKING AND USING | RAMIREZ, DELIA M | 1652 | §101§102§112 | Final Rejection | — | Pending | Oct 21, 2022 |
| 17843589 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | ROBINSON, HOPE A | 1652 | §112 | Final Rejection | 31d overdue | Pending | Jun 17, 2022 |
| 17780421 | ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-CoA-DERIVED PRODUCTS | QIAN, CELINE X | 1637 | §103§112 | Non-Final OA | — | Pending | May 26, 2022 |
| 15845398 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | HOBSON, STEPHEN | 1776 | §103 | Final Rejection | — | Pending | Dec 18, 2017 |
| 15651929 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | HOBSON, STEPHEN | 1776 | §103 | Non-Final OA | 10d overdue | Pending | Jul 17, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGenomatica Inc. has 13 pending office actions as of October 2026, spread across 7 art units and 10 examiners.
Tekchand Saidha has the most, with 2 of Genomatica Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
